BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16861931)

  • 1. Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction.
    Vazquez F; Devreotes P
    Cell Cycle; 2006 Jul; 5(14):1523-7. PubMed ID: 16861931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of cancer-associated PTEN mutations defined by membrane translocation defects.
    Nguyen HN; Yang JM; Rahdar M; Keniry M; Swaney KF; Parsons R; Park BH; Sesaki H; Devreotes PN; Iijima M
    Oncogene; 2015 Jul; 34(28):3737-43. PubMed ID: 25263454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering PTEN function: membrane association and activity.
    Yang JM; Nguyen HN; Sesaki H; Devreotes PN; Iijima M
    Methods; 2015 May; 77-78():119-24. PubMed ID: 25448479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium.
    Nguyen HN; Afkari Y; Senoo H; Sesaki H; Devreotes PN; Iijima M
    Oncogene; 2014 Dec; 33(50):5688-96. PubMed ID: 24292679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane.
    Vazquez F; Matsuoka S; Sellers WR; Yanagida T; Ueda M; Devreotes PN
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3633-8. PubMed ID: 16537447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Mechanisms of PTEN Regulation.
    Masson GR; Williams RL
    Cold Spring Harb Perspect Med; 2020 Mar; 10(3):. PubMed ID: 31636093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
    Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-binding and activation mechanism of PTEN.
    Das S; Dixon JE; Cho W
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7491-6. PubMed ID: 12808147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical methods for the characterization of PTEN/lipid bilayer interactions.
    Harishchandra RK; Neumann BM; Gericke A; Ross AH
    Methods; 2015 May; 77-78():125-35. PubMed ID: 25697761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function.
    Fernández-Acero T; Bertalmio E; Luna S; Mingo J; Bravo-Plaza I; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ
    Cells; 2019 Nov; 8(12):. PubMed ID: 31779149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane association of the PTEN tumor suppressor: molecular details of the protein-membrane complex from SPR binding studies and neutron reflection.
    Shenoy S; Shekhar P; Heinrich F; Daou MC; Gericke A; Ross AH; Lösche M
    PLoS One; 2012; 7(4):e32591. PubMed ID: 22505997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Chemical Approaches to Understanding PTEN Lipid Phosphatase Regulation.
    Dempsey DR; Cole PA
    Methods Enzymol; 2018; 607():405-422. PubMed ID: 30149868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutant form of PTEN linked to autism.
    Redfern RE; Daou MC; Li L; Munson M; Gericke A; Ross AH
    Protein Sci; 2010 Oct; 19(10):1948-56. PubMed ID: 20718038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the membrane-associated state of the PTEN tumor suppressor protein.
    Lumb CN; Sansom MS
    Biophys J; 2013 Feb; 104(3):613-21. PubMed ID: 23442912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opening the conformation is a master switch for the dual localization and phosphatase activity of PTEN.
    Nguyen HN; Yang JM; Miyamoto T; Itoh K; Rho E; Zhang Q; Inoue T; Devreotes PN; Sesaki H; Iijima M
    Sci Rep; 2015 Jul; 5():12600. PubMed ID: 26216063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutual inhibition between PTEN and PIP3 generates bistability for polarity in motile cells.
    Matsuoka S; Ueda M
    Nat Commun; 2018 Oct; 9(1):4481. PubMed ID: 30367048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering ePTEN, an enhanced PTEN with increased tumor suppressor activities.
    Nguyen HN; Yang JM; Afkari Y; Park BH; Sesaki H; Devreotes PN; Iijima M
    Proc Natl Acad Sci U S A; 2014 Jul; 111(26):E2684-93. PubMed ID: 24979808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into PTEN.
    Tamguney T; Stokoe D
    J Cell Sci; 2007 Dec; 120(Pt 23):4071-9. PubMed ID: 18032782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NHERFs, NEP, MAGUKs, and more: interactions that regulate PTEN.
    Bonifant CL; Kim JS; Waldman T
    J Cell Biochem; 2007 Nov; 102(4):878-85. PubMed ID: 17786934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.